BMS-986458 a Potential First-in-Class, Highly Selective, Potent and Well Tolerated BCL6 Ligand Directed Degrader (LDD) Demonstrates Multi-Modal Anti-Tumor Efficacy for the Treatment of B-Cell Non-Hodgkin's LymphomaLynda Groocock,Gauri Deb, Jinyi Zhu,Jim Gamez,Paola Castiglioni, Manuel Sanchez-Castillo, Justin Schumacher, Alicia Benitez Rondan,Diana Jankeel, Karla Martinez-Garcia,Scott Wood,Andy Christoforou,Carla Guarinos, Wei Zhang,Rama Krishna Narla,Christoph W. Zapf,Soraya Carrancio,Daniel W. Pierce,Mark Rolfe,Neil Bence,Antonia Lopez-Girona,Deborah S. MortensenBlood（2024）引用 0|浏览3AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
